Literature DB >> 26105823

Antibody Informatics: IMGT, the International ImMunoGeneTics Information System.

Marie-Paule Lefranc1.   

Abstract

Antibody informatics, a part of immunoinformatics, refers to the concepts, databases, and tools developed and used to explore and to analyze the particular properties of the immunoglobulins (IG) or antibodies, compared with conventional genes and proteins. Antibody informatics is based on a unique ontology, IMGT-ONTOLOGY, created in 1989 by IMGT, the international ImMunoGeneTics information system (http://www.imgt.org). IMGT-ONTOLOGY defined, for the first time, the concept of 'genes' for the IG and the T cell receptors (TR), which led to their gene and allele nomenclature and allowed their entry in databases and tools. A second IMGT-ONTOLOGY revolutionizing and definitive concept was the IMGT unique numbering that bridged the gap between sequences and structures for the variable (V) and constant (C) domains of the IG and TR, and for the groove (G) domains of the major histocompatibility (MH). These breakthroughs contributed to the development of IMGT databases and tools for antibody informatics and its diverse applications, such as repertoire analysis in infectious diseases, antibody engineering and humanization, and study of antibody/antigen interactions. Nucleotide sequences of antibody V domains from deep sequencing (Next Generation Sequencing or High Throughput Sequencing) are analyzed with IMGT/HighV-QUEST, the high-throughput version of IMGT/V-QUEST and IMGT/JunctionAnalysis. Amino acid sequences of V and C domains are represented with the IMGT/Collier-de-Perles tool and analyzed with IMGT/DomainGapAlign. Three-dimensional (3D) structures (including contact analysis and paratope/epitope) are described in IMGT/3Dstructure-DB. Based on a friendly interface, IMGT/mAb-DB contains therapeutic monoclonal antibodies (INN suffix-mab) that can be queried on their specificity, for example, in infectious diseases, on bacterial or viral targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26105823     DOI: 10.1128/microbiolspec.AID-0001-2012

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  8 in total

1.  Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.

Authors:  Mohammadreza Movahedin; Teresa M Brooks; Nitin T Supekar; Naveen Gokanapudi; Geert-Jan Boons; Cory L Brooks
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

2.  IMGT®, the international ImMunoGeneTics information system® 25 years on.

Authors:  Marie-Paule Lefranc; Véronique Giudicelli; Patrice Duroux; Joumana Jabado-Michaloud; Géraldine Folch; Safa Aouinti; Emilie Carillon; Hugo Duvergey; Amélie Houles; Typhaine Paysan-Lafosse; Saida Hadi-Saljoqi; Souphatta Sasorith; Gérard Lefranc; Sofia Kossida
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 19.160

3.  Transitional B Cells in Early Human B Cell Development - Time to Revisit the Paradigm?

Authors:  Victoria G Martin; Yu-Chang Bryan Wu; Catherine L Townsend; Grace H C Lu; Joselli Silva O'Hare; Alexander Mozeika; Anthonius C C Coolen; David Kipling; Franca Fraternali; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2016-12-02       Impact factor: 7.561

4.  Dataset of next-generation sequence reads of nanobody clones in phage display library derived from Indian desert camel (Camelus dromedarius L.).

Authors:  Somesh Banerjee; Ajit Singh; Jagveer Rawat; Nitish Bansal; Sushila Maan
Journal:  Data Brief       Date:  2020-12-16

Review 5.  VHH Structural Modelling Approaches: A Critical Review.

Authors:  Poonam Vishwakarma; Akhila Melarkode Vattekatte; Nicolas Shinada; Julien Diharce; Carla Martins; Frédéric Cadet; Fabrice Gardebien; Catherine Etchebest; Aravindan Arun Nadaradjane; Alexandre G de Brevern
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

6.  Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.

Authors:  Adéla Nacer; Gaily Kivi; Raini Pert; Erkki Juronen; Pavlo Holenya; Eduardo Aliprandini; Rogerio Amino; Olivier Silvie; Doris Quinkert; Yann Le Duff; Matthew Hurley; Ulf Reimer; Andres Tover; Simon J Draper; Sarah Gilbert; Mei Mei Ho; Paul W Bowyer
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

7.  4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.

Authors:  Daniele Veggi; Federica Bianchi; Laura Santini; Paola Lo Surdo; Chelsy C Chesterman; Werner Pansegrau; Nicoletta Bechi; Ying Huang; Vega Masignani; Mariagrazia Pizza; Rino Rappuoli; Matthew J Bottomley; Roberta Cozzi; Domenico Maione
Journal:  PLoS Pathog       Date:  2020-10-02       Impact factor: 6.823

8.  IMGT®Homo sapiens IG and TR Loci, Gene Order, CNV and Haplotypes: New Concepts as a Paradigm for Jawed Vertebrates Genome Assemblies.

Authors:  Marie-Paule Lefranc; Gérard Lefranc
Journal:  Biomolecules       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.